ags-16m8f
mAbexperimentalADC
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2010 (NCT01114230)
Timeline
Indications
Mechanism of action
- UnclearINHIBITOR
Unclear inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ags-16c3f
- ags-16m8f
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02639182 | Phase 2 | May 24, 2016 | Agensys, Inc. |
| NCT01672775 | Phase 1 | Jul 18, 2012 | Agensys, Inc. |
| NCT01114230 | Phase 1 | Aug 1, 2010 | Agensys, Inc., Astellas |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agensys, Inc. | For profit | 3 | 2 | 2 | 2010 |
| Astellas | For profit | 1 | 1 | 1 | 2010 |
2 organizations
Page 1 / 1